Elana Ferguson, NP
Psychiatric/Mental Health · Richmond, VANPI 1326749599
Payments from drug & device makers
Across 67 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$338
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$257
- Takeda Pharmaceuticals U.S.A., Inc.$131
- Teva Pharmaceuticals USA, Inc.$82
- Neurocrine Biosciences, Inc.$75
- Bausch Health US, LLC$68
- plus $269 from 7 others
What the payments were for
- Food & beverage$1,20999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $338 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $131 |
| Teva Pharmaceuticals USA, Inc. | 5 | $82 |
| Neurocrine Biosciences, Inc. | 4 | $75 |
| Bausch Health US, LLC | 3 | $68 |
| Alkermes, Inc. | 3 | $66 |
| Lundbeck LLC | 3 | $56 |
| Johnson & Johnson | 2 | $47 |
| Neos Therapeutics, LP | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $15 |
How this compares
$1,221 in reported general payments places this provider in the 70th percentile of 1,003 psychiatric/mental health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 21 | $2,827 |
| Olanzapine | 28 | $1,038 |
| Fluoxetine Hcl | 18 | $728 |
| Hydroxyzine Hcl | 32 | $326 |
| Lithium Carbonate ErLithium Carbonate | 20 | $322 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $279 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $269 |
| Buspirone Hcl | 14 | $217 |
| Escitalopram Oxalate | 30 | $192 |
| Benztropine Mesylate | 16 | $171 |
| Lamotrigine | 16 | $141 |
| Sertraline Hcl | 54 | $136 |
| Risperidone | 11 | $135 |
| Trazodone Hcl | 21 | $72 |
| Alprazolam | 18 | $6 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Richmond
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Abbie SmithRichmond$14K
- Thomas MamalakisRichmond$12K
- Monica MeyerRichmond$11K
- Vicky SpillerRichmond$10K
- Kimberly Southam-GerowRichmond$8K
- Charles McDonoughRichmond$7K
- Nympha DalgadoRichmond$7K
- Justin RayChesapeake$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.